Sputnik V due to submit vaccine data to WHO this month
Moscow rushed to approve the shot for domestic use last year and it has been exported to countries around the world, but it has still not been certified by either the WHO or the EMA...
December 22, 2021
by expresspharma
Russia says Argentina approves Sputnik Light as standalone and booster vaccine
Argentina was one of the first countries to widely use Russia's Sputnik V COVID-19 vaccine, but delays in deliveries led the country in August to offer second doses of Moderna and AstraZeneca vaccines to citizens who received the first dose of Russia's ..
December 7, 2021
by expresspharma
Putin hopes WHO soon approves Russia's Sputnik V vaccine
Russian President Vladimir Putin said Sunday that he hoped for a quick approval of the country's Sputnik V coronavirus vaccine by the World Health Organization, saying the move is essential for expanding global supplies, as reported by ABC News.
December 6, 2021
by PharmaTimes
Dr Reddy’s eyes Sputnik vaccine exports after domestic struggle
Dr Reddy’s Laboratories is in talks with partners to export domestically-made doses of Russia’s COVID-19 vaccine, Sputnik, after New Delhi recently approved shipments of other shots, the firm said yesterday.
November 30, 2021
by ExpressPharma
Russia says Sputnik vaccine should work against Omicron, can produce boosters
Russia on Monday said it would be ready to provide booster shots to protect against the Omicron coronavirus variant if needed, as reported in the National Post.
November 30, 2021
by FirstWordPharma
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effecti
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the interim results of the study in Argentina on heterogeneous regimens combining Sputnik Light ...
October 15, 2021
by prnasia
One-shot Sputnik Light vaccine (first component of the Sputnik V vaccine) demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination, Gamaleya C
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) and Gamaleya National Research Center of Epidemiology and Microbiology today announced the results of an efficacy analysis...
October 14, 2021
by prnasia
SII to commence manufacturing of Sputnik COVID-19 vaccine in September
As per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the vaccine in India per year.
July 14, 2021
by expresspharma
Snowman Logistics partners with Dr Reddy’s for Sputnik COVID-19 vaccine in India
Snowman will offer storage, order processing, shipper packing and secondary transportation from its temperature-controlled warehouses in Mumbai, Delhi-NCR, Kolkata, Chennai, and Bengaluru.
June 4, 2021
by expresspharma